Why the study?
What is the failure rate and clinical manifestation of failure for the Medtronic 4012 polyurethane bipolar tined pacing lead?
Cohort (n=1,190)
Yes
What is the failure rate and clinical manifestation of failure for the Medtronic 4012 polyurethane bipolar tined pacing lead?
Answers are grounded in this paper and cite their sources.
The Medtronic 4012 pacing lead has an unacceptably high failure rate of 20.9% at 6 years due to insulation problems, prompting recommendations for prophylactic replacement in pacemaker-dependent patients.
A multicenter study was undertaken to determine the failure rate of a specific polyurethane bipolar tined pacing lead, the Medtronic 4012 pacing lead. Six centers in the United States and Canada implanted 1,190 Medtronic 4012 pacing leads. The study was designed to determine the probability and clinical manifestations of lead failure. Only failures compatible with an insulation problem were included. The probability of a 4012 lead failure by Kaplan-Meier analysis was 20.9% at 6 years after implantation. Failures were manifested as sensing abnormalities, failure to capture, early battery depletion, and significant decrease in measured impedance compared with the previous impedance measurements. Of the 95 definite lead failures, 16 (16.8%) were associated with symptoms similar to those experienced before pacemaker placement. The observed failure rate is unacceptable, and strong consideration should be given to replacing the 4012 pacing lead in pacemaker-dependent patients and closely monitoring nondependent patients.
No takes yet. Share an insight, caveat, or question.
Hayes et al. (1992) conducted a cohort in Patients requiring ventricular pacing (n=1,190). Medtronic 4012 pacing lead was evaluated on Probability of lead failure compatible with an insulation problem.
Synapse has enriched 10 related papers. Consider them for comparative context: